Genital Neoplasms, Male D005834

Related MeSH Hierarchy (5)

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Urogenital Neoplasms » Genital Neoplasms, Male

Diseases [C] » Urogenital Diseases [C12] » Genital Diseases » Genital Diseases, Male » Genital Neoplasms, Male

Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Genital Diseases, Male » Genital Neoplasms, Male

Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urogenital Neoplasms » Genital Neoplasms, Male

Diseases [C] » Urogenital Diseases [C12] » Urogenital Neoplasms » Genital Neoplasms, Male

Description

Tumor or cancer of the MALE GENITALIA.   MeSH

Hierarchy View

Subtype Terms (3)

Penile Neoplasms
46 drugs (29 approved, 17 experimental)

Prostatic Neoplasms
971 drugs (358 approved, 613 experimental)

Testicular Neoplasms
138 drugs (90 approved, 48 experimental)


Phase 1 Indicated Drugs (3)

Other Experimental Indicated Drugs (2)


Organization Involved with Phase 4 Indications (2)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.